{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T14:14:29Z","timestamp":1754144069336,"version":"3.41.2"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072891"],"award-info":[{"award-number":["82072891"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To assess CIN3+ risk in a Chinese cohort of outpatients undergoing contesting screening and to evaluate the portability of the American Society for Colposcopy and Cervical Pathology (ASCCP) risk-based management, which was primarily developed using data from the Kaiser Permanente of Northern California (KPNC) cohort.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Females aged 25-65 years who were screened with cytology and high-risk human papillomavirus (hrHPV) co-testing between 2011 and 2020 at Wuhan Union Hospital (WHUH) were retrospectively studied. The risks of immediate and 3-year CIN3+ were estimated via prevalence-incidence mixture models. Portability was evaluated via the ratio of the observation risk in the WHUH cohort to the expected risk in the KPNC cohort (O\/E) and its 95% CI.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 96 318 females were included, and 16.83% of the women tested hrHPV-positive at initial screening, who had a CIN3+ immediate risk of 14.14%. The CIN3+ immediate risk varied between subgroups of positive HPV16 (34.09%), HPV18 (13.38%), other HPV types (6.71%), and negative hrHPV (0.12%). Compared to the KPNC cohort, our cohort exhibited a significantly higher CIN3+ immediate risk (1.42% vs 0.46%; O\/E, 3.09; 95% CI, 2.92-3.26) and disproportionately increased cancer immediate risks in most subgroups requiring immediate colposcopy or treatment, as well as higher 3-year CIN3+ risks in women with hrHPV-negative ASC-US\/NILM. Yet, the action threshold suggested by ASCCP, a CIN3+ immediate risk of 4%, showed good portability to our cohort.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Despite the higher risks in our cohort, the ASCCP clinical action threshold remains portable. For women with minimal abnormalities or normal results, shortened follow-up intervals should be considered.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/oncolo\/oyaf197","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T01:55:26Z","timestamp":1751334926000},"source":"Crossref","is-referenced-by-count":0,"title":["Risk assessment in a Chinese cohort of 96 318 females undergoing opportunistic cervical cancer screening"],"prefix":"10.1093","volume":"30","author":[{"given":"Jing","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan 430022 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan 430022 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zehua","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan 430022 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weichao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Maternal and Child Health Hospital of Hubei Province , Wuhan 430022 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan 430022 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liying","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan 430022 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan 430022 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoqing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan 430022 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongya","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan 430022 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dingyu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan 430022 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinglan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan 430022 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wuliang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gynecology, The Second Affiliated Hospital of Zhengzhou University, Henan Provincial Clinical Research Center for Gynecologic Oncology , Zhengzhou 450014 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqiong","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan 430022 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bangxing","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan 430022 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0302-9998","authenticated-orcid":false,"given":"Jing","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan 430022 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"key":"2025071500314103200_CIT0001","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"2025071500314103200_CIT0002","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3760\/cma.j.cn112152-20240119-00035","article-title":"Cancer incidence and mortality in China, 2022","volume":"46","author":"Zheng","year":"2024","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"2025071500314103200_CIT0003","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1001\/jama.2020.16244","article-title":"Lifetime prevalence of cervical cancer screening in 55 low- and middle-income countries","volume":"324","author":"Lemp","year":"2020","journal-title":"JAMA"},{"key":"2025071500314103200_CIT0004","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3390\/ijerph14090967","article-title":"Assessing knowledge and attitudes towards cervical cancer screening among rural women in Eastern China","volume":"14","author":"Liu","year":"2017","journal-title":"Int J Environ Res Public Health"},{"key":"2025071500314103200_CIT0005","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors","volume":"24","author":"Perkins","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"2025071500314103200_CIT0006","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1097\/AOG.0000000000001721","article-title":"Similar risk patterns after cervical screening in two large U.S. populations: implications for clinical guidelines","volume":"128","author":"Gage","year":"2016","journal-title":"Obstet Gynecol"},{"key":"2025071500314103200_CIT0007","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/LGT.0000000000000528","article-title":"2019 ASCCP risk-based management consensus guidelines: methods for risk estimation, recommended management, and validation","volume":"24","author":"Cheung","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"2025071500314103200_CIT0008","doi-asserted-by":"publisher","first-page":"e197","DOI":"10.1016\/S2214-109X(22)00501-0","article-title":"Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative","volume":"11","author":"Singh","year":"2023","journal-title":"Lancet Glob Health"},{"key":"2025071500314103200_CIT0009","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S1470-2045(20)30674-4","article-title":"Comparison of breast cancer and cervical cancer stage distributions in ten newly independent states of the former Soviet Union: a population-based study","volume":"22","author":"Ryzhov","year":"2021","journal-title":"Lancet Oncol"},{"key":"2025071500314103200_CIT0010","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.ypmed.2017.12.004","article-title":"Challenges in risk estimation using routinely collected clinical data: the example of estimating cervical cancer risks from electronic health-records","volume":"111","author":"Landy","year":"2018","journal-title":"Prev Med"},{"key":"2025071500314103200_CIT0011","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3389\/fonc.2020.00449","article-title":"Multi-infection patterns and co-infection preference of 27 human papillomavirus types among 137,943 gynecological outpatients across China","volume":"10","author":"Liao","year":"2020","journal-title":"Front Oncol"},{"key":"2025071500314103200_CIT0012","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/jmv.25451","article-title":"A direct comparison of four high-risk human papillomavirus tests versus the cobas test: detecting CIN2+ in low-resource settings","volume":"91","author":"Xue","year":"2019","journal-title":"J Med Virol"},{"key":"2025071500314103200_CIT0013","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.ajog.2007.07.047","article-title":"2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests","volume":"197","author":"Wright","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"2025071500314103200_CIT0014","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1097\/AOG.0b013e3182883a34","article-title":"2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"121","author":"Massad","year":"2013","journal-title":"Obstet Gynecol"},{"key":"2025071500314103200_CIT0015","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1214\/17-AOAS1036","article-title":"Flexible risk prediction models for left or interval-censored data from electronic health records","volume":"11","author":"Hyun","year":"2017","journal-title":"Ann Appl Stat"},{"key":"2025071500314103200_CIT0016","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1002\/sim.7380","article-title":"Mixture models for undiagnosed prevalent disease and interval-censored incident disease: applications to a cohort assembled from electronic health records","volume":"36","author":"Cheung","year":"2017","journal-title":"Stat Med"},{"key":"2025071500314103200_CIT0017","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/LGT.0000000000000529","article-title":"Risk estimates supporting the 2019 ASCCP risk-based management consensus guidelines","volume":"24","author":"Egemen","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"2025071500314103200_CIT0018","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/LGT.0000000000000685","article-title":"Risk-based cervical consensus guidelines: methods to determine management if less than 5 years of data are available","volume":"26","author":"Egemen","year":"2022","journal-title":"J Low Genit Tract Dis"},{"key":"2025071500314103200_CIT0019","doi-asserted-by":"publisher","first-page":"e1115","DOI":"10.1016\/S2214-109X(22)00241-8","article-title":"Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis","volume":"10","author":"Bruni","year":"2022","journal-title":"Lancet Glob Health"},{"key":"2025071500314103200_CIT0020","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.cmi.2019.09.006","article-title":"Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans","volume":"26","author":"Maver","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"2025071500314103200_CIT0021","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0140-6736(20)30068-4","article-title":"Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries","volume":"395","author":"Brisson","year":"2020","journal-title":"Lancet"},{"key":"2025071500314103200_CIT0022","doi-asserted-by":"publisher","first-page":"e075925","DOI":"10.1136\/bmj-2023-075925","article-title":"Untreated cervical intraepithelial neoplasia grade 2 and subsequent risk of cervical cancer: population based cohort study","volume":"383","author":"Lycke","year":"2023","journal-title":"Bmj"},{"key":"2025071500314103200_CIT0023","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.2147\/IDR.S471176","article-title":"Prevalence and genotype distribution of human papillomavirus infection among women in Wuhan, China: a retrospective study","volume":"17","author":"Wang","year":"2024","journal-title":"Infect Drug Resist"},{"key":"2025071500314103200_CIT0024","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s12916-023-02965-w","article-title":"Risk factors for human papillomavirus infection, cervical intraepithelial neoplasia and cervical cancer: an umbrella review and follow-up Mendelian randomisation studies","volume":"21","author":"Bowden","year":"2023","journal-title":"BMC Med"},{"key":"2025071500314103200_CIT0025","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"2025071500314103200_CIT0026","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0140-6736(09)61394-5","article-title":"Women\u2019s health in rural China","volume":"374","year":"2009","journal-title":"Lancet"},{"key":"2025071500314103200_CIT0027","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1016\/j.vaccine.2010.12.085","article-title":"Prevention of cervical cancer in rural China: evaluation of HPV vaccination and primary HPV screening strategies","volume":"29","author":"Canfell","year":"2011","journal-title":"Vaccine"},{"key":"2025071500314103200_CIT0028","doi-asserted-by":"publisher","first-page":"5103","DOI":"10.1002\/jmv.27013","article-title":"Prevalence and genotype distribution of high-risk HPV infection among women in Beijing, China","volume":"93","author":"Zhu","year":"2021","journal-title":"J Med Virol"},{"key":"2025071500314103200_CIT0029","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12905-023-02166-w","article-title":"Human papilloma virus infection and its associated risk for cervical lesions: a cross-sectional study in Putuo area of Shanghai, China","volume":"23","author":"Luan","year":"2023","journal-title":"BMC Womens Health"},{"key":"2025071500314103200_CIT0030","doi-asserted-by":"publisher","first-page":"137","DOI":"10.4103\/joc.joc_42_22","article-title":"The prevalence of cervical HPV infection and genotype distribution in 856,535 Chinese women with normal and abnormal cervical lesions: a systemic review","volume":"39","author":"Yu","year":"2022","journal-title":"J Cytol."},{"key":"2025071500314103200_CIT0031","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","article-title":"Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study","volume":"9","author":"McCredie","year":"2008","journal-title":"Lancet Oncol"},{"key":"2025071500314103200_CIT0032","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/LGT.0000000000000530","article-title":"A study of partial human papillomavirus genotyping in support of the 2019 ASCCP risk-based management consensus guidelines","volume":"24","author":"Demarco","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"2025071500314103200_CIT0033","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/jnci\/dji187","article-title":"The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice","volume":"97","author":"Khan","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"2025071500314103200_CIT0034","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ijc.27680","article-title":"Incidence risk of cervical intraepithelial neoplasia 3 or more severe lesions is a function of human papillomavirus genotypes and severity of cytological and histological abnormalities in adult Japanese women","volume":"132","author":"Hosaka","year":"2013","journal-title":"Int J Cancer"},{"key":"2025071500314103200_CIT0035","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1002\/ijc.27485","article-title":"Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer","volume":"131","author":"Guan","year":"2012","journal-title":"Int J Cancer"},{"key":"2025071500314103200_CIT0036","doi-asserted-by":"publisher","first-page":"366.e1","DOI":"10.1016\/j.ajog.2020.10.001","article-title":"Risk of cervical precancer and cancer among uninsured and underserved women from 2009 to 2017","volume":"224","author":"Saraiya","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"2025071500314103200_CIT0037","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/LGT.0000000000000852","article-title":"Validation of the 2019 American Society of Colposcopy and cervical pathology online cervical cancer screening program via 9 large-cohort data of Chinese women","volume":"29","author":"Dai","year":"2025","journal-title":"J Low Genit Tract Dis"},{"key":"2025071500314103200_CIT0038","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1002\/ijc.34902","article-title":"The impact of loss to follow-up in the Dutch organised HPV-based cervical cancer screening programme","volume":"154","author":"Olthof","year":"2024","journal-title":"Int J Cancer"},{"key":"2025071500314103200_CIT0039","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3322\/caac.21452","article-title":"Timely follow-up of positive cancer screening results: a systematic review and recommendations from the PROSPR Consortium","volume":"68","author":"Doubeni","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"2025071500314103200_CIT0040","doi-asserted-by":"publisher","first-page":"413","DOI":"10.46234\/ccdcw2024.080","article-title":"Estimated human papillomavirus vaccine coverage among females 9-45 years of age - China, 2017-2022","volume":"6","author":"Chen","year":"2024","journal-title":"China CDC Wkly"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/oncolo\/advance-article-pdf\/doi\/10.1093\/oncolo\/oyaf197\/63631588\/oyaf197.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/30\/7\/oyaf197\/63631588\/oyaf197.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/30\/7\/oyaf197\/63631588\/oyaf197.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T04:31:51Z","timestamp":1752553911000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/doi\/10.1093\/oncolo\/oyaf197\/8179156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7,4]]}},"URL":"https:\/\/doi.org\/10.1093\/oncolo\/oyaf197","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"type":"print","value":"1083-7159"},{"type":"electronic","value":"1549-490X"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,7]]},"article-number":"oyaf197"}}